Filar I, Witkowski M, Ryżewska W, Robak T. Recombinant ADAMT S-13 as a new alternative for the patients with congenital thrombocytopenic purpura. OncoReview [Internet]. 2024Dec.31 [cited 2025Feb.23];14(3(55):59-3. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/3198